Randomized Phase 2 Study on the Relationship Between Circulating VEGF and Weekly or Every-Four-Week Zometa [zoledronic acid] in Breast Cancer Patients With Bone Metastases.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Advanced breast cancer; Breast cancer; Cancer metastases
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 12 Oct 2009 Status changed from active, no longer recruiting to completed.
- 12 Oct 2009 Results have been presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.
- 10 Oct 2009 Results presented at the 2009 Breast Cancer Symposium